Role of first-trimester HbA1c as a predictor of adverse obstetric outcomes in a multiethnic cohort

Journal of Clinical Endocrinology and Metabolism

Volumn 102, Issue 2, 2017, Pages 390-397

  Mane, Laura ^a,b   Flores Le Roux, Juana Antonia ^a,c   Benaiges, David ^a,c   Rodriguez, Marta ^c   Marcelo, Irene ^c   Chillaron, Juan Jose ^a,c   Pedro Botet, Juan ^a,c   Llaurado, Gemma ^a   Gortazar, Lucia ^a   Carreras, Ramon ^a,c   Paya, Antonio ^a,c  

^a HOSPITAL DEL MAR   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ADVERSE OUTCOME; CESAREAN SECTION; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MACROSOMIA; MAJOR CLINICAL STUDY; PREDICTION; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PROSPECTIVE STUDY;

EID: 85012106637     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-2581     Document Type: Conference Paper

References (40)

1. Soriguer F, Goday A, Bosch-Comas A, Bordíu E, Calle-Pascual A, Carmena R, Casamitjana R, Castaño L, Castell C, Catalá M, Delgado E, Franch J, Gaztambide S, Girbés J, Gomis R, Gutiérrez G, López-Alba A, Martínez-Larrad MT, Meneńdez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Martínez G, Serrano-Rios M, Valdés S, Vázquez JA, Vendrell J. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study. Diabetologia. 2011;55(1):88-93.
2. Feig DS, Razzaq A, Sykora K, Hux JE, Anderson GM. Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes: A population-based study in Ontario, Canada, 1996-2001. Diabetes Care. 2006;29(2):232-235.
3. Lawrence JM, Contreras R, Chen W, Sacks DA. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care. 2008;31(5):899-904.
4. Lapolla A, Dalfrà MG, Lencioni C, Di Cianni G. Epidemiology of diabetes in pregnancy: A review of Italian data. Diabetes Nutr Metab. 2004;17(6):358-367.
5. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002.
6. American Diabetes Association. Introduction. Diabetes Care. 2016;39(suppl 1):S1-S2.
7. Radder JK, van Roosmalen J. HbA1c in healthy, pregnant women. Neth J Med. 2005;63(7):256-259.
8. Rafat D, Ahmad J. HbA1c in pregnancy. Diabetes Metab Syndr. 2012;6(1):59-64.
9. Nielsen LR, Ekbom P, Damm P, Glümer C, Frandsen MM, Jensen DM, Mathiesen ER. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care. 2004;27(5):1200-1201.
10. Hughes RC, Rowan J, Florkowski CM. Is there a role for HbA1c in pregnancy?. Curr Diabetes Rep. 2016;16(1):5.
11. Rowan JA, Budden A, Ivanova V, Hughes RC, Sadler LC. Women with an HbA1c of 41-49 mmol/mol (5.9-6.6%): A higher risk subgroup that may benefit from early pregnancy intervention. Diabetes Med. 2015;33(1):25-31.
12. Hughes RC, Moore MP, Gullam JE, Mohamed K, Rowan J. An early pregnancy HbA1c "5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care. 2014;37(11):2953-2959.
13. Hartland AJ, Smith JM, Clark PM, Webber J, Chowdhury T, Dunne F. Establishing trimester- and ethnic group-related reference ranges for fructosamine and HbA1c in non-diabetic pregnant women. Ann Clin Biochem. 1999;36(2):235-237.
14. Bleyer AJ, Hire D, Russell GB, Xu J, Divers J, Shihabi Z, Bowden DW, Freedman BI. Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin. Diabetes Med. 2009;26(2):128-133.
15. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007;30(10):2453-2457.
16. Likhari T, Gama R. Glycaemia-independent ethnic differences in HbA(1c) in subjects with impaired glucose tolerance. Diabetes Med. 2009;26(10):1068-1069.
17. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown M.A. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement fromthe ISSHP. PregnancyHypertens. 2014;4(2):97-104.
18. Amylidi S, Mosimann B, Stettler C, Fiedler GM, Surbek D, Raio L. First-trimester glycosylated hemoglobin in women at high risk for gestational diabetes. Acta Obstet Gynecol Scand. 2015;95(1): 93-97.
19. Aulinas A, Biagetti B, Vinagre I, Capel I, Ubeda J, María MÁ, García-Patterson A, Adelantado JM, Ginovart G, Corcoy R. Gestational diabetes mellitus and maternal ethnicity: High prevalence of fetal macrosomia in non-Caucasian women [in Spanish]. Med Clin (Barc). 2013;141(6):240-245.
20. SchmidtMI, Duncan BB, Reichelt AJ, Branchtein L,MatosMC,Costa e Forti A, Spichler ER, Pousada JM, Teixeira MM, Yamashita T; Brazilian Gestational Diabetes Study Group. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care. 2001;24(7):1151-1155.
21. Richardson C, Trotman H. Risk factors for the delivery of macrosomic infants at the University Hospital of the West Indies. Am J Perinatol. 2014;31(11):927-932.
22. Nielsen GL, Sørensen HT, Nielsen PH, Sabroe S, Olsen J. Glycosylated hemoglobin as predictor of adverse fetal outcome in type 1 diabetic pregnancies. Acta Diabetol. 1997;34(3):217-222.
23. Nielsen GL, Møller M, Sørensen HT. HbA1c in early diabetic pregnancy and pregnancy outcomes: A Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes. Diabetes Care. 2006;29(12):2612-2616.
24. Gold AE, Reilly R, Little J, Walker JD. The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM. Diabetes Care. 1998;21(4):535-538.
25. Page RC, Kirk BA, Fay T, Wilcox M, Hosking DJ, Jeffcoate WJ. Is macrosomia associated with poor glycaemic control in diabetic pregnancy?. Diabetes Med. 1996;13(2):170-174.
26. Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Moelsted- Pedersen L,Westergaard JG,MoellerM,DammP. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care. 2009;32(6):1046-1048.
27. Lowe LP, Metzger BE, Dyer AR, Lowe J, McCance DR, Lappin TR, Trimble ER, Coustan DR, Hadden DR, Hod M, Oats JJ, Persson B; HAPOStudyCooperative ResearchGroup. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: Associations of maternal A1C and glucosewith pregnancy outcomes. Diabetes Care. 2012;35(3):574-580.
28. Capula C, MazzaT, VeroR, CostanteG. HbA1c levels in patients with gestational diabetesmellitus: Relationshipwith pre-pregnancyBMIand pregnancy outcome. J Endocrinol Invest. 2013;36(11):1038-1045.
29. Hardy DS. A multiethnic study of the predictors of macrosomia. Diabetes Educ. 1999;25(6):925-933.
30. Henriksen T. The macrosomic fetus: A challenge in current obstetrics. Acta Obstet Gynecol Scand. 2008;87(2):134-145.
31. Alsammani MA, Ahmed S.R. Fetal and maternal outcomes in pregnancies complicated with fetal macrosomia. North Am J Med Sci. 2012;4(6):283-286.
32. Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S. Risk factors for macrosomia and its clinical consequences: A study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol. 2003;111(1): 9-14.
33. Alberico S, Montico M, Barresi V, Monasta L, Businelli C, Soini V, Erenbourg A, Ronfani L, Maso G; Multicentre Study Group on Mode of Delivery in Friuli Venezia Giulia. The role of gestational diabetes, pre-pregnancy body mass index and gestational weight gain on the risk of newborn macrosomia: Results from a prospective multicentre study. BMC Pregnancy Childbirth. 2014;14:23.
34. Ahmad J, Rafat D. HbA1c and iron deficiency: A review. Diabetes Metab Syndr. 2013;7(2):118-122.
35. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112(3):126-128.
36. Kim C, Bullard KM, Herman WH, Beckles GL. Association between iron deficiency and A1C levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2010;33(4):780-785.
37. Benaiges D, Chillaron JJ, Pedro-Botet J, Mas A, Puig de Dou J, Sagarra E, Carrera MJ, Goday A, Flores-Le Roux JA. Role of A1c in the postpartum screening of women with gestational diabetes. Gynecol Endocrinol. 2013;29(7):687-690.
38. Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P. Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. Adults. Diabetes Care. 2010;33(10):2190-2195.
39. Saukkonen T, Cederberg H, Jokelainen J, LaaksoM, Härkönen P, Keinänen-Kiukaanniemi S, Rajala U. Limited overlap between intermediate hyperglycemia as defined by A1C 5.7-6.4%, impaired fasting glucose, and impaired glucose tolerance. Diabetes Care. 2011;34(10):2314-2316.
40. Crofts J, Draycott TJ, Montague I, Winter C, Fox R, on behalf of the Royal College of Obstetricians and Gynaecologists. Shoulder Dystocia. Green-top Guideline No. 42. 2nd ed. London: NICE; 2012.